Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.1, 2010-01, pp. : 22-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Significant Increase in Natural-killer T Cells in Patients with Tuberculosis Complicated by Type 2 Diabetes Mellitus

By Zhang Q Xiao H-P Cui H-Y Sugawara I

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 105-111

Field House Publishing

Access to resources Recommend Favorite

Gastric electrical stimulation improves glycaemic control and weight loss among obese patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite